Figure 3A illustrates the eNOS-NO-sGC-cGMP-PKG pathway and its contribution to oxidative stress and insulin resistance in HFpEF patients with and without diabetes (Fig. )3B–H). This evidence concerns the gene NOS3 and Insulin resistance.